Scientists have developed a compact, low-cost biosensor that could revolutionize HIV monitoring in resource-limited regions. The device, detailed in a study published on April 9, 2025, in Microsystems & Nanoengineering, uses microfluidic technology to accurately measure CD4+ T cell counts—a key indicator of immune health in HIV patients—without the need for complex lab equipment.
Breaking Down Barriers in HIV Care
Traditional methods like flow cytometry are highly accurate but expensive and impractical for remote settings. The new biosensor, created by researchers from the University of Bath and Nanyang Technological University, addresses these challenges by combining electrochemical impedance spectroscopy with a lab-on-a-chip design. This innovation enables precise, label-free detection of CD4+ cells with minimal manual input, making it ideal for point-of-care use.
How the Device Works
The biosensor features a microfluidic chip with gold electrodes functionalized with anti-CD4 antibodies. When a blood sample passes through the chip, the electrodes detect CD4+ cells by measuring changes in electrical impedance. The device boasts a detection range of 1.25 × 10⁵ to 2 × 10⁶ cells/mL and a sensitivity sufficient for clinical use, even in advanced HIV cases. Its modular design also allows for integration with cell separation technology, streamlining the entire diagnostic process.
A Step Toward Global Health Equity
“Our goal was to create an affordable, user-friendly tool that brings high-quality HIV monitoring to underserved areas,” said Professor Pedro Estrela, the study’s lead author. The biosensor’s portability, low fabrication cost, and potential for automation could significantly improve access to timely diagnostics, particularly in regions with limited healthcare infrastructure.
Future Prospects
Next steps include refining the device for whole blood testing and conducting clinical trials. If successful, this technology could pave the way for decentralized HIV care, empowering healthcare workers with reliable, on-the-spot diagnostics and improving treatment outcomes worldwide.
Add comment